Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 1, 1973CancerOpen Access

CCNU (1-2-chloroethyl-3-cyclohexyl-1-nitrosourea, NSC-79037) in the treatment of cancer. Phase II study

View Full Paper
Ask AI
Bookmark
Share

Authors

BHBarth HoogstratenHonda (Japan)JGJeffrey A. GottliebNational Cancer InstituteECEulogio CaoiliUniversity of Michigan

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hoogstraten et al. (1973) studied this question.

synapsesocial.com/papers/6a7926af06f2b779205addaehttps://doi.org/10.1002/1097-0142(197307)32:1<38::aid-cncr2820320105>3.0.co;2-i
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Therapy of advanced gastrointestinal cancer with 1‐3‐bis‐(2‐chlorethyl)‐l‐nitrosourea (BCNU)1968 · 22 citations
  2. 2Treatment of Advanced Hodgkin’s Disease with [1,3 Bis (2-Chloroethyl)-1-Nitrosourea] BCNU1971 · 57 citations
  3. 3BCNU (1,3), BIS(B-chloroethyl)-1-nitrosourea. Effects on advanced Hodgkin's disease and other neoplasia1968 · 79 citations